["{\"step_by_step_thinking\": \"None of the provided documents mention CAR-T cell therapies or B cell malignancies. The topics discussed include gene targeting for generating mutant mice, bone marrow purging prior to autologous transplantation, development and testing of packaging cell lines for avian retroviral vectors, and cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors. Therefore, there is no relevant information in the provided documents regarding CAR-T cell therapies or their approval for treating B cell malignancies.\", \"answer_choice\": \"B\"}"]